go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd

GlaxoSmithKline Consumer Healthcare (Ireland) Ltd
Stonemason's Way, Rathfarnham, Dublin 16,
Telephone: +353 1 495 5000
Fax: +353 1 495 5105
Medical Information Direct Line: +353 1 800 244 255
Medical Information Facsimile: +353 1 495 5242
Summary of Product Characteristics last updated on medicines.ie: 01/09/2011
SPC Day Nurse Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 01/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to paediatric information
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   29-Aug-2011
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company



4.2 Posology and method of administration
Children 6 to 12 years: One capsule every four hours, up to a maximum of 3 doses in 24 hours if needed.

Children under 612 years: Not to be given to children under 612 years of age.


4.3       Contraindications

Do not give to children under 12 years of age.

Updated on 26/10/2010 and displayed until 01/09/2011
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   01-Sep-2010
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company

In section 1 (name of the medicinal product) the active ingredients and strengths were added.

In section 2 (Qualitative and Quantitative Composition)  the following was added:

"lso contains Allura Red (E129)

For a full list of excipients see section 6.1."

In section 3 (Pharmaceutical form) capsule was placed in brackets after hard. and "It contains a white powder" was added at the end of the last sentence in the section.

In section 6.1 (List of excipients)  a subheading "Capsule Content" was added at the start .

In section 6.5 (Nature and contents of container), "Not all pack sizes may be marketed" was added.

In section 9 (Date of Authorisation/Renewal of the Authorisation), the text was changed to read as follows:
Date of first authorisation: 04 November 2003
Date of last authorisation: 04 November 2008

In section 10 (date of revision of the text) the date was changed to September 2010

Updated on 19/08/2008 and displayed until 26/10/2010
Reasons for adding or updating:
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   06/2005
Legal Category:   retail sale through pharmacy only

Free-text change information supplied by the pharmaceutical company

Section 10 Change in date of revision of the text from May 2005 to June 2005

Updated on 09/01/2008 and displayed until 19/08/2008
Reasons for adding or updating:
  • Change to section 6.1 - List of excipients
Date of revision of text on the SPC:   05/2005
Legal Category:   prescription only

Free-text change information supplied by the pharmaceutical company

Section 6.1 List of excipients

Sodium lauryl sulphate
Sodium starch glycollate
Magnesium stearate
Hard gelatine capsule
(containing: Gelatin, Quinoline yellow (E104), Allura red (E129), Titanium dioxide (E171).)
Black print ink
(containing: Shellac, Iron oxide black (E172), Propylene glycol.)
Updated on 28/06/2005 and displayed until 09/01/2008
Reasons for adding or updating:
  • Change to section 6.3 - Shelf life
  • Change to section 6.4 - Special precautions for storage
Updated on 04/06/2004 and displayed until 28/06/2005
Reasons for adding or updating:
  • New SPC for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Paracetamol
   Pholcodine
   Pseudoephedrine Hydrochloride

Versions

 
01/09/2011 to Current
26/10/2010 to 01/09/2011
19/08/2008 to 26/10/2010
09/01/2008 to 19/08/2008
28/06/2005 to 09/01/2008
04/06/2004 to 28/06/2005
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo